HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$14.96
Year range
$2.86 - $36.26
Market cap
1.30B USD
Avg Volume
1.84M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 50.08M | 36.22% |
Net income | -46.06M | -37.22% |
Net profit margin | — | — |
Earnings per share | -0.50 | 1.96% |
EBITDA | -49.90M | -36.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 505.44M | 16.44% |
Total assets | 533.43M | 18.28% |
Total liabilities | 54.87M | 30.60% |
Total equity | 478.56M | — |
Shares outstanding | 87.16M | — |
Price to book | 2.54 | — |
Return on assets | -28.27% | — |
Return on capital | -31.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -46.06M | -37.22% |
Cash from operations | -38.33M | -45.82% |
Cash from investing | -162.18M | -41.74% |
Cash from financing | 213.55M | -12.59% |
Net change in cash | 13.04M | -87.41% |
Free cash flow | -21.30M | -219.22% |
About
Founded
2006
Headquarters
Website
Employees
131
